Condition
Natriuretic Peptide, Brain
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07099859Phase 4Recruiting
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
NCT03351283Not ApplicableCompleted
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
NCT03926104Unknown
BNP and Vascular Surgery
NCT00560040Completed
Myocardial Injury is Not Related to Training Levels Among Recreational Participants in the Silicon Valley Marathon
NCT00528736Completed
Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks
Showing all 5 trials